Bolt Biotherapeutics, Inc.
Bolt Biotherapeutics, Inc.（BOLT）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
bolt · 股价预测 · 8 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 8 位华尔街分析师
Hold
8 位分析师
共识
评级分布
12 个月目标价
High
$7.00
Consensus
$4.00
-15.3% upside
Low
$1.00
Median: $4 · Last Close: $4.72
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$4.00
-15.3% upside
High Target
$7
48.3%
Low Target
$1
-78.8%
Current Price
$4.72
as of today
Based on analyst price targets, the BOLT stock price prediction for the next 12 months ranges from $1 to $7. The consensus BOLT price forecast of $4.00 implies -15.3% upside from the current price of $4.72.
短期股价预测
Low Activity算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $4.65 | ↓ 1.48% |
1-day model range: $4.56–$4.74. Peak: $4.74 (-1.48%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | — | -50.0% |
| 2028 | — | -62.5% |
| 2029 | — | -67.2% |
| 2030 | — | -69.2% |
| 2031 | — | -70.2% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Insufficient Trading Activity — Sentiment Signals Disabled
This stock has very low trading volume (ZOMBIE condition). Sentiment analysis requires sufficient price action. RSI and MACD values below are still shown for reference.
Moving Averages · BOLT · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-28 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-03-13 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-08-15 | Lake Street | Maintains | Buy→Buy |
| 2025-05-13 | Stifel | Maintains | Hold→Hold |
| 2025-03-25 | Stifel | Maintains | Hold→Hold |
| 2025-03-25 | HC Wainwright & Co. | Maintains | Neutral→Neutral |
| 2024-05-15 | Leerink Partners | Downgrade ↓ | Outperform→Market Perform |
| 2024-05-15 | Stifel | Downgrade ↓ | Buy→Hold |
| 2024-05-15 | Guggenheim | Downgrade ↓ | Buy→Neutral |
| 2024-05-15 | HC Wainwright & Co. | Downgrade ↓ | Buy→Neutral |
Wall Street analysts have recently issued updated ratings on Bolt Biotherapeutics, Inc. (BOLT) stock. Of the recent 30 rating actions, 1 were upgrades and 7 were downgrades. 8 analysts currently cover BOLT.
分析师推荐趋势
BOLT analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 1 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$1M
↓ 71.7% YoY
Revenue Next Year
$2M
↑ 106.2% YoY
EPS This Year
$-15.88
EPS Next Year
$-19.93
↑ 25.5% YoY
EPS ForecastReported vs Estimated
Analysts forecast BOLT EPS of $-15.88 for the current fiscal year, based on estimates from 2 analysts. The BOLT revenue forecast is $1M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
BOLT 股价预测由两类独立数据源支撑：来自 8 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。BOLT 的共识目标价为 $4.00（-15.3% 上行空间），分析师共识为 Hold。
BOLT 的短期预测（明日）为 $4.65（-1.48%）。 BOLT 对 2030 年的预测区间为 $1–$2。
Bolt Biotherapeutics, Inc. 在 NASDAQ 上市，代码 BOLT。BOLT 在 2027 年的整体展望偏中性/分化，在覆盖分析师中约 38% 对应 Hold 共识。
常见问题
BOLT 预测 · 8 个问题根据 8 位华尔街分析师，BOLT 的 12 个月平均目标价为 $4.00，最高 $7.00、最低 $1.00。若有图表，中位目标价可在上方查看。相对当前价 $4.72，隐含约 -15.3% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.